Bacterial superantigen vaccines
AssigneeThe United States of America as represented by the Secretary of the Army
InventorsRobert G. Ulrích, Mark A. Olson, Sina Bavari
Life of this patent
Estimating the term…
Abstract
The present invention relates to genetically attenuated superantigen toxin vaccines altered such that superantigen attributes are absent, however the superantigen is effectively recognized and an appropriate immune response is produced. The attenuated superantigen toxins are shown to protect animals against challenge with wild type toxin. Methods of producing and using the altered superantigen toxins are described.
Claims4
An isolated and purified superantigen toxin Staphylococcal enterotoxin B (SEB) in which amino acid Tyr at position 115 is substituted with Ala, amino acid Tyr at position 89 is substituted with Ala, amino acid Glu at position 67 is substituted with Gln, or amino acid Tyr at position 94 is substituted with Ala, such that binding of the altered toxin to either the MHC class II or T cell antigen receptor is altered.
An isolated and purified Staphylcoccal enterotoxin B (SEB) superantigen toxin comprising the amino acid sequence of SEQ ID NO:6.
An isolated and purified Staphylcoccal enterotoxin B (SEB) superantigen toxin comprising the amino acid sequence of SEQ ID NO:8.
An isolated and purified Staphylcoccal enterotoxin B (SEB) superantigen toxin comprising the amino acid sequence of SEQ ID NO:10.
Dependencies are inferred from the claim text.